Altimmune (NASDAQ:ALT) is in a good place right now, especially when you consider that the one drug it has in its pipeline is ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver ...

Tonal shifts were inevitable, but no one could've expected the radical Season 4 episode that exclusively featured one ...

Savvy investors are picking the next big crypto right at the presale. Monsta Mash stands out because of its massive growth potential, diverse utility, future adaptability by institutions, and vibrant ...

The Falcons have had their fair share of injuries this season, but it’s hit a breaking point in Week 11. On Wednesday, the ...

The Phase 3 findings position semaglutide to become the first drug of its kind for the liver disease. But they also confirm ...

Glucagon-like peptide-1 (GLP-1) receptor agonists have gained attention as potential treatments for a variety of ...

With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing ...

The "Monster Mash" was more than just a graveyard smash — it was also banned in the U.K. for many years! Learn about the ...

Late-night host Jimmy Kimmel’s satirical mash-up featuring former US presidents Barack Obama and Donald Trump will never get ...

Cardano’s rally picks up momentum and its market activity surges significantly. Monsta Mash’s presale warms up to enter its ...

This article reveals the top 3 crypto gems with the potential for explosive growth in 2025. For those seeking the next big ...